01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $1.41B
6 older moves run past ±150% (largest −5043.8%); point at, tap or drag across the bars to read one.
02—Ledger
Net Income, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $1.41B | +186.0% | 10-K | |
| FY2024 | −$1.64B | −193.2% | 10-K | |
| FY2023 | −$559.0M | +77.1% | 10-K | |
| FY2022 | −$2.45B | −686.6% | 10-K | |
| FY2021 | $417.0M | +110.5% | 10-K | |
| FY2020 | −$3.99B | −299.4% | 10-K | |
| FY2019 | −$999.0M | +53.5% | 10-K | |
| FY2018 | −$2.15B | +86.8% | 10-K | |
| FY2017 | −$16.27B | −5043.8% | 10-K | |
| FY2016 | $329.0M | −79.4% | 10-K | |
| FY2015 | $1.60B | −47.7% | 10-K | |
| FY2014 | $3.06B | +140.7% | 10-K | |
| FY2013 | $1.27B | −35.4% | 10-K | |
| FY2012 | $1.96B | −28.9% | 10-K | |
| FY2011 | $2.76B | −17.2% | 10-K | |
| FY2010 | $3.33B | +66.5% | 10-K | |
| FY2009 | $2.00B | +228.4% | 10-K | |
| FY2008 | $609.0M | −68.2% | 10-K | |
| FY2007 | $1.91B | — | 10-K |
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is Teva Pharmaceutical Industries's current net income?
Teva Pharmaceutical Industries (TEVA) annual net income for 2025 was $1.41B, a 186.03% increase from 2024. Teva Pharmaceutical Industries net income for the quarter ending September 30, 2026 was $233.0M.
What was Teva Pharmaceutical Industries's net income in 2024?
Teva Pharmaceutical Industries annual net income for 2024 was $-1.64B, a 193.20% decline from 2023.
What was Teva Pharmaceutical Industries's net income in 2023?
Teva Pharmaceutical Industries annual net income for 2023 was $-559.0M, a 77.15% increase from 2022.
- Company
- Teva Pharmaceutical Industries
- Ticker
- TEVA
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations